Results 241 to 250 of about 66,631 (315)

Evaluating the Performance of Different Substrates for Preparing Enzyme-Immobilized Bioreactors. [PDF]

ACS Omega
Jannat M, Chakma S, Junayed M, Dhrubo AAK.   +3 more
europepmc   +1 more source

Nonthermal plasma approaches for combating implant‐associated infections: A compendious review

VIEW, EarlyView.
Implant‐associated infections pose serious clinical challenges. Non‐thermal plasma (NTP) modifications overcome this bottleneck in distinct ways relative to traditional sterilization methods. Gas‐phase plasmas generate highly energetic species, UV radiation and reactive oxygen/nitrogen species (RONS), which alter the implant surface properties.
A. M. Trimukhe, Satish Rojekar, Amol Gholap, K. Navaneetha Pandiyaraj, Mukesh Patekar, Claudia Riccardi, R. R. Deshmukh, Tomáš Kovářík, Kalim Deshmukh   +8 more
wiley   +1 more source

A pumpless liver-adipose model for studying metabolic dysfunction and drug responses. [PDF]

PLoS One
Ebrahimian Z, Kalalinia F, Ameri AR, Hosseinzadeh H, Razavi BM, Mousavi Shaegh SA.   +5 more
europepmc   +1 more source

Effect of the microbiome on pathogen susceptibility across four Drosophilidae species

Insect Science, EarlyView.
Four Drosophilidae species were used to investigate how variation in the host microbiome influences susceptibility to infection. Microbial composition and abundance differed among species and treatments. The effects of microbiome manipulation on host survival were both species‐ and pathogen‐specific.
Hongbo Sun, Ben Longdon, Ben Raymond
wiley   +1 more source

Integrative circulatory engineering for regenerative therapy: Dynamic perfusion design and metabolic maturation in cardiac tissue engineering. [PDF]

Regen Ther
Homma J, Sekine H.
europepmc   +1 more source

Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy

Alimentary Pharmacology &Therapeutics, EarlyView.
The gut microbiome modulates ulcerative colitis pharmacotherapy through microbial drug metabolism, immune regulation and altered drug bioavailability. Microbial composition influences response to aminosalicylates, corticosteroids, immunomodulators, biologics and small molecules, while microbiome‐targeted therapies show emerging promise.
Kate Collins, Srinivas Kamath, Rachel H. Davis, Samuel P. Costello, Robert V. Bryant, Alice S. Day, Paul Joyce   +6 more
wiley   +1 more source

Effects of bioreactor inoculation method on secondary metabolite production and morphological characteristics of Streptomyces rimosus in microparticle-enhanced cultivation (MPEC). [PDF]

Microb Cell Fact
Ścigaczewska A, Boruta T, Bizukojć M.
europepmc   +1 more source

Ensuring Good Transferability from Pilot- to Large-Scale Optimized Biotech Bubble Column Designs. [PDF]

Bioengineering (Basel)
Link C, Bromley J, Martin M, Takors R.
europepmc   +1 more source

Miniature bioreactor arrays for modeling functional and structural dysbiosis in inflammatory bowel disease. [PDF]

Gut Microbes
Newman KL, Standke AK, James G, Vendrov KC, Inohara N, Bergin IL, Higgins PDR, Rao K, Young VB, Kamada N.   +9 more
europepmc   +1 more source

Enrichment and characterization of steroid-degrading microbes for targeted removal of steroid hormone micropollutants in small-scale wastewater treatment solutions. [PDF]

Microbiol Spectr
Kujala K, Nübel LL, Philipp B, Holert J.   +3 more
europepmc   +1 more source